Codon 325 sequence polymorphism of the estrogen receptor α gene and bone mineral density in postmenopausal women

https://doi.org/10.1016/S0960-0760(01)00069-3Get rights and content

Abstract

Estrogen receptor α (ERα) encoding gene is one of the candidate genes to be involved in the development of osteoporosis. Until now correlation between three ER gene polymorphisms (identified with PvuII, XbaI and BstUI) and bone mineral density (BMD) have been investigated. The results of these studies are contradictory. Thus the aim of our work was to search for new, yet unknown, and probably more informative polymorphism(s) of the ERα gene. For detection of mutations the whole coding region of the ERα gene was screened systematically. In a group of 85 late postmenopausal women all of the eight exons were amplified by polymerase chain reaction (PCR) and fragments were further analyzed by single-stranded conformation polymorphism (SSCP) analysis. Mutations were confirmed by direct DNA sequencing. In the whole coding region of the ERα gene two silent mutations in codon 87 and 325, respectively, were found. The silent mutation in codon 85 of exon 1 (GCG  GCC; A87A) was described previously, as BstUI polymorphism. On the other side, the silent mutation in codon 325 (CCC  CCG; P325P), located in exon 4, has not been analyzed so far in correlation with BMD. According to the distribution of genotypes CC:CG:GG=49.4:41.2:9.4, we can affirm the existence of genetic polymorphism in codon 325 in our population of late postmenopausal women. The mean femoral neck BMD, but not the lumbar spine BMD, was significantly lower (P=0.029) in the homozygous GG-women with CCG/CCG codon 325 as compared to the homozygous CC-women with the normal codon CCC/CCC. Our results suggest that codon 325 sequence polymorphism of the ERα gene might be one of the factors associated with low femoral neck BMD.

Introduction

Osteoporosis is a multifactorial disease, characterized by low bone mass and increased fracture risk [1]. Various environmental factors such as dietary calcium, physical activity, smoking habits and alcohol intake together with body weight and menopausal status, influence the bone mass [2]. However, most authors agree that here genetic factors are major determinants [3], [4], [5], [6], [7], [8], [9]. A great deal is known about the factors that regulate bone turnover and the proteins that compose bone matrix. This gives us a wide range of potential, candidate genes which may be involved in the development of osteoporosis. Estrogen receptor α (ERα) gene is one of them because estrogens regulate bone turnover and skeletal growth.

ERα is a nuclear regulatory protein that mediates the actions of estrogens in target cells. Binding of an estrogen causes conformational changes of the receptor protein and increases its affinity for DNA resulting in transcription activation or repression of a target gene [10]. However, in spite of the wide variety of estrogen actions in different tissues, relatively few genes are known which are responsive to the ERα.

The gene coding for ERα is located on chromosome 6q25.1. It extends over more than 140 kb and includes eight exons with sizes of 684, 191, 117, 336, 139, 134, 184 and 4537 bp, respectively (6322 bp in total); 232 nucleotides on the 5′-end and 4305 nucleotides on the 3′-end of the mRNA are not translated [11].

Until now three polymorphisms of the ERα gene have been investigated in connection with bone mineral density (BMD) (15,10,8). PvuII (T  C) and XbaI (A  G) polymorphisms have been found in intron 1 while BstUI polymorphism (silent mutation in codon 87: GCG  GCC; Ala  Ala) has been localized in exon 1. The study, where the relationship between PvuII and XbaI restriction fragment length polymorphisms (RFLP) and BMD has been analyzed in 238 Japanese subjects, showed that some genotypes are associated with low BMD [12]. A group of Korean researchers has carried out a similar research, in which also BstUI RFLP was included [13]. In this studies no significant relationship between ERα genotypes and Z-scores of lumbar spine BMD was found. Some of the research groups have performed studies where correlation of both ERα and vitamin D receptor gene polymorphisms with BMD have been studied [14], [15], [16], [17]. Their results have shown correlation of particular genotypes to low BMD. Furthermore, the newest results of Sowers et al. [18] again confirmed the contribution of sex hormone genes to variations of BMD.

According to the contradictory results of these studies we decided to look for the possibility of a new, yet unknown, polymorphism(s) of the ERα gene which could be associated with BMD. The whole coding region of the ERα gene in a group of 53 postmenopausal women was analyzed using PCR, single-stranded conformation analysis (SSCP), and direct sequencing of DNA fragments.

Section snippets

Patients

Eighty-five consecutive late postmenopausal female patients (in menopause >6 years), aged 55–74 years (mean 65.5 years), who were referred to the Outpatient Department of Endocrinology at the University Clinical Centre in Ljubljana for measurement of bone mineral density, were evaluated. Each patient was examined clinically and routine biochemical tests were performed to exclude systemic and metabolic bone disease. None had previously taken any drug known to influence bone metabolism.

The study

Results

SSCP analysis showed mobility shift of the samples only in exons 1 and 4 (Fig. 1). Direct DNA sequence analysis of those samples revealed two silent mutations, in codon 87 (GCG  GCC; A87A) and 325 (CCC  CCG; P325P), respectively.

In codon 87 only four heterozygous and no homozygous GCC subjects were found.

In codon 325 42 subjects were homozygous for the normal CCC codon (genotype CC), eight subjects were homozygous for the mutated codon CCG̱ (genotype GG) and 35 subjects were heterozygous CCC̱

Discussion

In the whole coding region of the ERα gene two silent mutations in codon 87 and 325, respectively, were found. The silent mutation in codon 85 of exon 1 (GCG  GCC; A87A) has been described previously, as BstUI polymorphism. The silent mutation in codon 325 (CCC  CCG; P325P), located in exon 4, has not been analyzed so far in correlation with BMD. According to the distribution of genotypes CC:CG:GG=49.4:41.2:9.4, we can affirm the existence of genetic polymorphism in codon 325 in our population of

Acknowledgements

This work was supported by grant J1-8762-0381 provided by the Ministry of Science and Technology of Slovenia. The authors are grateful to L. Strmecki, PhD and K. Vouk, MSc for technical assistance.

References (27)

  • J.C. Reese et al.

    Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor

    J. Biol. Chem.

    (1991)
  • H. Iwase et al.

    Sequence variants of estrogene receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors

    Cancer Lett.

    (1996)
  • J.A. Kanis et al.

    Guidelines for diagnosis and management of osteoporosis

    Osteoporosis Int.

    (1997)
  • E.A. Krall et al.

    Heritable and life-style determinants of bone mineral density

    J. Bone Miner. Res.

    (1993)
  • S.H. Ralston

    Osteoporosis

    Br. Med. J.

    (1997)
  • M. Garabedian

    Genetic aspects of osteoporosis

    Curr. Opin. Rheumatol.

    (1995)
  • J.A. Kahn et al.

    Osteoporosis and genetic influence: a three-generation study

    Postgrad. Med. J.

    (1994)
  • C.W. Slemenda et al.

    Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates

    J. Bone Miner. Res.

    (1991)
  • N.A. Peacock et al.

    Genetic determinants of bone mass in adults: a twin study

    J. Clin. Invest.

    (1987)
  • R. Armamento-Villareal et al.

    Estrogen status and heredity are major determinants of premenopausal bone mass

    J. Clin. Invest.

    (1992)
  • J.C. Christian et al.

    Heritability of bone mass: a longitudinal study in aging male twins

    Am. J. Hum. Genet.

    (1989)
  • M. Ponglikitmongkol et al.

    Genomic organization of the human oestrogen receptor gene

    EMBO J.

    (1988)
  • S. Kobaya Hi et al.

    Association of bone mineral density with polymorphisms of the estrogen receptor gene

    J. Bone Miner. Res.

    (1996)
  • Cited by (27)

    • A comprehensive overview on osteoporosis and its risk factors

      2018, Therapeutics and Clinical Risk Management
    View all citing articles on Scopus
    View full text